HUTCHMED
63 hedge funds and large institutions have $91.7M invested in HUTCHMED in 2025 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 19 increasing their positions, 20 reducing their positions, and 8 closing their positions.
2.73% more ownership
Funds ownership: 0.76% → 3.49% (+2.7%)
0% more funds holding
Funds holding: 63 → 63 (0)
0% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 8
5% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 20
8% less capital invested
Capital invested by funds: $99.9M → $91.7M (-$8.2M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $73K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$2.85M |
| 2 |
NIM
NEOS Investment Management
Westport,
Connecticut
|
+$622K |
| 3 |
TE
Tema ETFs
New York
|
+$622K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$472K |
| 5 |
CGH
Crossmark Global Holdings
Houston,
Texas
|
+$385K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Schroder Investment Management Group
London,
United Kingdom
|
-$3.86M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2.22M |
| 3 |
XC
XY Capital
Central,
Hong Kong
|
-$1.46M |
| 4 |
Allianz Asset Management
Munich,
Germany
|
-$1.17M |
| 5 |
BlackRock
New York
|
-$794K |
HCM Hedge Fund Activity: Q2 2025 in Review
63 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in HUTCHMED (HCM) for Q2 2025, worth a combined $91.7M — down 8.2% from $99.9M a quarter earlier.
Fund positioning in HCM was balanced in Q2 2025: 8 funds opened new positions, 8 closed out, 19 added to existing stakes and 20 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $2.85M. The largest seller was Schroder Investment Management Group, cutting an estimated $3.86M.
- 63 institutional investors held HUTCHMED (HCM) as of Q2 2025, unchanged from Q1 2025.
- Funds reported $91.7M of HUTCHMED stock for Q2 2025, down 8.2% quarter-over-quarter.
- 8 funds opened new HUTCHMED positions in Q2 2025 and 8 closed out, a net change of 0 holders.
- The largest HUTCHMED buyer in Q2 2025 was Goldman Sachs, an estimated $2.85M added.
- The largest HUTCHMED seller in Q2 2025 was Schroder Investment Management Group, an estimated $3.86M sold.
Based on aggregated 13F filings for Q2 2025.